Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

This project is part of the EDCTP3 programme supported by the European Union

Share:

Opinion: Malaria clinical research must include pregnant women

Malaria is a dangerous disease. One that, according to the World Health Organization, resulted in 249 million cases and 608,000 deaths in 2022 worldwide. For pregnant women, particularly those in their first trimester, it can cause serious complications, a concern for over 120 million women of childbearing age living in malaria-endemic areas. Malaria in pregnancy can result in maternal and neonatal mortality, miscarriage, low birth weight, and stillbirth.

United Nations member states adopted the Sustainable Development Goals in 2015, which include Goal 3 of ensuring healthy lives and promoting well-being for all at all ages, and Goal 5 of achieving gender equality and empowering all women and girls by 2030. The SDGs include specific targets for ending malaria, ending all forms of discrimination against women and girls, and achieving universal health coverage. However, medicines can take 20 years to be approved for use in pregnant women; time that the global health community does not have if it is to meet the 2030 deadline to achieve these goals.  

To view the full article, please visit the Devex website.